biote Corp. Files 8-K on Security Holder Vote Matters

TL;DR

biote Corp. (BTMD) filed an 8-K for a shareholder vote - watch for updates.

AI Summary

On May 21, 2024, biote Corp. filed an 8-K report detailing a submission of matters to a vote of security holders. The company, formerly known as Haymaker Acquisition Corp. III, is based in Irving, Texas, and operates in the medicinal chemicals and botanical products sector.

Why It Matters

This filing indicates that biote Corp. is engaging its security holders in important corporate decisions, which could impact the company's future direction and shareholder value.

Risk Assessment

Risk Level: low — The filing is a routine procedural report regarding a vote of security holders and does not disclose any immediate financial distress or significant negative events.

Key Numbers

• 001-40128 — SEC File Number (Identifies the company's filing with the SEC.)
• 85-1791125 — IRS Employer Identification No. (Company's tax identification number.)

Key Players & Entities

• biote Corp. (company) — Registrant
• Haymaker Acquisition Corp. III (company) — Former company name
• Irving, Texas (location) — Principal executive offices
• May 21, 2024 (date) — Date of earliest event reported

FAQ

Key Financial Figures

• $0.0001 — stered Class A common stock, par value $0.0001 per share BTMD The Nasdaq Stock Mar

Filing Documents

• d822374d8k.htm (8-K) — 29KB
• 0001193125-24-146528.txt ( ) — 149KB
• btmd-20240521.xsd (EX-101.SCH) — 3KB
• btmd-20240521_lab.xml (EX-101.LAB) — 18KB
• btmd-20240521_pre.xml (EX-101.PRE) — 11KB
• d822374d8k_htm.xml (XML) — 4KB

From the Filing

8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 21, 2024 biote Corp. (Exact name of registrant as specified in its charter) Delaware 001-40128 85-1791125 (State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer Identification No.) 1875 W. Walnut Hill Ln #100 Irving , Texas 75038 (Address of principal executive offices, including zip code) (844) 604-1246 (Registrant's telephone number, including area code) (Former name or former address, if changed since last report) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbols Name of each exchange on which registered Class A common stock, par value $0.0001 per share BTMD The Nasdaq Stock Market LLC Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) Pre-commencements communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (240.12b-2 of this chapter). Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item5.07 Submission of Matters to a Vote of Security Holders. On May 21, 2024, biote Corp., a Delaware corporation (the "Company"), held its 2024 annual meeting of stockholders (the "Annual Meeting"). Below are detailed voting results on each matter voted on which are described in more detail in the Company's definitive proxy statement for the Annual Meeting filed with the Securities and Exchange Commission on April 11, 2024 (the "Proxy Statement"). Proposal 1: Election of Directors The Company's stockholders elected the three individuals listed below to serve as Class II directors until the Company's 2027 annual meeting of stockholders and until their successors are duly elected and qualified or until their earlier death, resignation or removal. The final voting results are as follows: Nominee For Withheld Broker Non-Votes Steven J. Heyer 39,570,108 6,471,544 5,285,359 S. Mark Cone 41,383,463 4,742,536 5,201,012 Debra L. Morris 40,009,750 6,116,249 5,201,012 Proposal 2: Ratification of Appointment of Independent Registered Public Accounting Firm The Company's stockholders ratified the selection of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024. The final voting results are as follows: For Against Abstain Broker Non-Votes 47,312,863 3,771,943 242,205 0 SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. biote Corp. By: /s/ Teresa S. Weber Name: Teresa S. Weber Title: Chief Executive Officer Date: May 24, 2024

View Full Filing

View this 8-K filing on SEC EDGAR